Study of Thyroid Dysfunction in Immune Thrombocytopenic Purpura Patients
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Sohag University
- Trial code
- NCT07900334
- Record updated
- 28 October 2026
- Original description
Study of relation between thyroid dysfunction and immune thrombocytopenic purpura patients and if there is relation between themRead full original descriptionShow less
Study of Thyroid Dysfunction in Patients With Immune Thrombocytopenic Purpura at Sohag University Hospital
Study of relation between thyroid dysfunction and immune thrombocytopenic purpura patients and if there is relation between them
Inclusion: 1. Patient newly diagnosed immune thrombocytopenia; 2- No current thyroid therapy; 3-Able to provide informed consent and required clinical data (age, sex, ITP duration/therapy, bleeding history.
Exclusion: 1. Known thyroid disease or prior thyroid therapy:; Prior thyroidectomy, radioiodine, antithyroid drugs, or levothyroxine; Acute or critical illness within the past 4-6 weeks (non-thyroidal illness syndrome); ICU admission, major surgery, severe infection/trauma; Medications that acutely suppress or distort TSH around sampling; High-dose glucocorticoids, dopamine/dobutamine infusions.